Yiling Pharmaceutical Co., Ltd. announced on Friday that it had received the approvals of the Abbreviated New Drug Applications (ANDA) about Lisinopril Tablets and Acyclovir Capsules, from United States Food and Drug Administration (hereinafter referred to as the "FDA"), which were submitted by Yiling Wanzhou International Pharmaceutical Co., Ltd., one of the wholly-owned subsidiaries of Yiling Pharmaceutical Co., Ltd., meaning that these products are approved to be produced and sold i...
PRNEWSWIRE
READ MORE
|
Shares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on its multi-billion dollar cancer drug Revlimid, a decision that could ease shareholder tensions ahead of a potential merger with Bristol-Myers Squibb. Celgene’s biggest-selling drug Revlimid (lenalidomide) is used in several multiple myeloma uses and has been on the US market since 2005. Since then Celgene has built one of the world’s most lucrative drug franchises around Revlimid, a de...
READ MORE
|